Abstract
To explore possible applications of iodoacetate (IA), a glycolytic inhibitor, in cancer treatment, we screened its cytotoxicity and radioprotective/sensitizing efficacy in three different mammalian cell lines; A549 (human lung carcinoma), MCF7 (human mammary cancer), a non-cancerous CHO (Chinese hamster ovary) cells and human lymphocytes. Experiments were carried out using IA concentrations ranging from 0.01 to 2.5 µg/ml, with or without 60Coγ-radiation. In the outcomes, IA was found to exhibit higher toxicity in the cancer cells, whereas it was non-toxic/marginally toxic to the non-cancerous cells. Considerably higher glucose uptake in both cancer cells lines was observed indicating higher rates of glycolysis. IA significantly inhibited glycolysis as reflected by GAPDH activity inhibition. Radiomodifying effects of IA were found to be concentration dependent in both cancerous and non-cancerous cells. The response in non-cancerous was found to be biphasic: at lower concentrations, it offered significant radioprotection; however, the protection decreased with increasing concentration. Moreover, at the highest tested concentration, marginal radiosensitization was also observed (as indicated by clonogenic assay). In both cancer cells, IA offered significant amount of radiosensitization which was considerably high at higher concentrations. Further experiments were carried out to estimate the Dose Modification Factor (DMF) to quantify and compare relative radiosensitization by IA in cancer and normal cell lines. The DMF was calculated for three different concentrations of IA, 0.5, 1, and 1.5 µg/ml, and corresponding values were found to be 1.26, 1.43, and 1.89 for A549 cancer cells, whereas for normal CHO cells, it was 1.13, 1.13, and 1.24. In conclusion, differential killing and radiosensitizing effects of IA suggest that it may have potential use as a anticancer agent and radiosensitizer in cancer therapy.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig6_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig7_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig8_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig9_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig10_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig11_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig12_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00411-017-0699-0/MediaObjects/411_2017_699_Fig13_HTML.gif)
Similar content being viewed by others
References
Anjaria KB, Bhat NN, Shirsath KB (2008) Modification of gamma radiation and 4-nitroquinoline 1-oxide induced genotoxicity by tumour promoter Iodoacetate. Int. J Hum Genet 8(3):307–315
Anjaria KB, Shirsath KB, Bhat NN, Sreedevi B (2010) Effect of tumour promoter iodoacetate on γ-radiation induced chromosomal aberrations in human lymphocytes. Radiat Prot Environ 33:199
Apffel CA, Arnason BG, Peters JH (1966) Induction of tumour immunity with tumour cells treated with iodoacetate. Nature 209:694–696
Badwey JA, Karnovsky ML (1980) Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem 49:695–726
Bhardwaj V, Rizvi N, Lai MB et al (2010) Glycolytic enzyme inhibitors affect pancreatic cancer survival by modulating its signaling and energetics. Anticancer Res 30:743–749
Bhushan A, Chatterji T, Wong W et al (2014) Iodoacetate and 3-bromopyruvate exert differential effects on human neuronal tumor SK-N-SH and U-87 cells. Cancer Res 74:3371–3371
Bonnet S, Archer SL, Allalunis-Turner J et al (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11:37–51
Connell JR, Duncan SJ (1981) The effect of non-phorbol promoters as compared with phorbol myristate acetate on sister chromatid exchange induction in cultured Chinese hamster cells. Cancer Lett 11:351–356
Dwarakanath BS (2009) Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-d-glucose in vitro. J Cancer Res Ther 5:27
Dwarakanath BS, Jain VK (1985) Enhancement of radiation damage by 2-deoxy-d-glucose in organ cultures of brain tumours. Indian J Med Res 82:266
Dwarkanath BS, Jain VK (1989) Energy linked modifications of the radiation response in a human cerebral glioma cell line. Int J Radiat Oncol Biol Phys 17:1033–1040
Fahim FA, Esmat AY, Mady EA, Ibrahim EK (2003) Antitumor activities of iodoacetate and dimethylsulphoxide against solid Ehrlich carcinoma growth in mice. Biol Res 36:253–262
Farooque A, Afrin F, Adhikari JS, Dwarakanath BS (2009) Protection of normal cells and tissues during radio-and chemosensitization of tumors by 2-deoxy-d-glucose. J Cancer Res Ther 5:32
Fenech M (2007) Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084–1104
Gatenby RA, Gawlinski ET, Gmitro AF et al (2006) Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 66:5216–5223
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Harada H (2011) How can we overcome tumor hypoxia in radiation therapy? J Radiat Res (Tokyo) 52:545–556.
Hipkiss AR (2006) On the mechanisms of ageing suppression by dietary restriction—is persistent glycolysis the problem? Mech Ageing Dev 127:8–15
International atomic energy agency (2011) Cytogenetic dosimetry: applications in preparedness for and response to radiation emergencies. IAEA, Vienna
Izumi H, Takahashi M, Uramoto H et al (2011) Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci 102:1007–1013
Jain VK, Kalia VK, Gopinath PM et al (1979) Optimization of cancer therapy: Part III—Effects of combining 2-deoxy-d-glucose treatment with gamma-irradiation on normal mice. Indian J Exp Biol 17:1320
Kalia VK, Jain VK, Otto FJ (1982) Optimization of cancer therapy: Part IV—effects of 2-deoxy-d-glucose on radiation induced chromosomal damage in PHA-stimulated peripheral human leukocytes. Indian J Exp Biol 20(12):884–888
Kinsella AR (1982) Elimination of metabolic co-operation and the induction of sister chromatid exchanges are not properties common to all promoting or co-carcinogenic agents. Carcinogenesis 3:499–503
Mohanti BK, Rath GK, Anantha N et al (1996) Improving cancer radiotherapy with 2-deoxy-d-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys 35:103–111
Murugesan R, Jayaraman G, Gopinath PM (1996) Modulatory effect of 2-deoxy-d-glucose on radiation-induced genetic damage. Biomedicine 16:61–66
Pelicano H, Martin DS, Xu, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25:4633–4646
Perumal V, Solomon PF, Jayanth VR (2009) Modification of 2-deoxy-d-glucose on radiation-and chemotherapeutic drug-induced chromosomal aberrations. J Cancer Res Ther 5:48
Prabhu BK, Gowri B, Muthuvelu K et al (2004) Effect of 2-deoxy-d-glucose on the induction of chromosomal aberrations in lymphocytes exposed in vitro to gamma radiation at a dose rate of 1.0 Gy/minute. Int. J Hum Genet 4:45
Ramakrishnan V, Kumar SG, Madhusudhanan N et al (2011) Effect of 2-deoxy-d-Glucose and cyclophosphamide mediated modification of induced genetic damage in Albino Mice. Int J Biol Pharm Res 2:11–18
Rheins MS, Filppi JA, Moore VS (1975) Effect of iodoacetate on the bone marrow immunocompetence of AKR mice. Cancer Res 35:1514–1519
Sabri MI, Ochs S (1971) Inhibition of glyceraldehyde-3-phosphate dehydrogenase in mammalian nerve by Idoacetic acid. J Neurochem 18:1509–1514
Schmidt M, Dringen R (2009) Differential effects of iodoacetamide and iodoacetate on glycolysis and glutathione metabolism of cultured astrocytes. Front Neuroenerg 1:1
Singh SP, Jayanth VR, Chandna S et al (1998) Radioprotective effects of DNA ligands Hoechst-33342 and 33258 in whole body irradiated mice. Indian J Exp Biol 36:375–384
Singh D, Banerji AK, Dwarakanath BS et al (2005) Optimizing cancer radiotherapy with 2-deoxy-d-glucose. Strahlenther Onkol 181:507–514
Singh SP, Singh S, Jain V (2009) Effects of 5-bromo-2-deoxyuridine and 2-deoxy-d-glucose on radiation-induced micronuclei in mouse bone marrow. Int J Radiat Biol 58:791–797 (Received 28 Dec 1989, Accepted 10 May 1990, Published online: 03 Jul 2009)
Wainwright SD, Mullaney J (1953) Some effects of metabolic inhibitors upon survival of ultra-violet irradiated Escherichia coli. Cell Mol Life Sci 9:376–377
Warburg O (1956) On the origin of cancer cells. Science 123:309–314
Wuttke K (1996) Micronuclei in lymphocytes of children from the vicinity of chernobyl before and after 131I therapy for thyroid cancer. Int J Radiat Biol 69:259–268
Zhong D, Xiong L, Liu T et al (2009) The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R. J Biol Chem 284:23225–23233
Acknowledgements
We acknowledge the technical assistance by Mr. Tondlekar P., Mr. Jagtap S. and Mr. Thorat U.B. Flow-cytometry-related assistance was rendered by Mr. Prayag A. We also sincerely acknowledge support and guidance by Dr. Pradeepkumar K.S., Associate Director, HS&E Group, BARC and Mr. D.A.R. Babu, Ex-Head, RP&AD, BARC.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Yadav, U., Anjaria, K.B., Nairy, R. et al. Differential killing and radio-modifying effects of iodoacetate in mammalian normal and cancer cells. Radiat Environ Biophys 56, 227–239 (2017). https://doi.org/10.1007/s00411-017-0699-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00411-017-0699-0